Physicians and Physician Trainees Rarely Identify or Address Overweight/Obesity in Hospitalized Children

Marta A King1, Flory L Nkoy2, Christopher G Maloney2

  • 1Department of Pediatrics Saint Louis University, St. Louis, MO.

Insights

Physicians and trainees seldom document overweight/obesity in hospitalized children, missing crucial care opportunities. This study highlights a gap in pediatric obesity management and medical education.

Area of Science:

  • Pediatric hospital medicine
  • Medical education
  • Public health

Background:

  • Overweight and obesity are significant pediatric health concerns.
  • Effective management requires consistent identification and intervention by healthcare providers.
  • Hospitalized children represent a critical population for addressing weight-related health issues.

Purpose of the Study:

  • To assess the frequency of overweight/obesity identification and management by physicians in hospitalized children.
  • To compare documentation practices across different physician training levels (medical student, intern, resident, attending).

Main Methods:

  • Retrospective chart review of 300 hospitalized children (aged 2-18) with overweight/obesity.
  • Utilized administrative data and CDC BMI calculator.
  • Analyzed admission, progress, and discharge notes for documentation of identification and addressing of overweight/obesity.

Main Results:

  • Overweight/obesity was identified in only 8.3% and addressed in 4% of cases.
  • Documentation varied by training level: interns most often in history, attendings in physical exam/assessment/plan.
  • Medical students showed the lowest documentation rates in assessment and plan.

Conclusions:

  • Physicians and trainees infrequently identify or address overweight/obesity in hospitalized children.
  • This represents a missed opportunity for patient care and physician training in obesity management.
  • Improved documentation and education are needed for pediatric obesity.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
343
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
394
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
287
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
769
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
1.1K